Penumbra, Inc. (PEN) Financials

PEN Assets vs Liabilities

DateAssetsLiabilities
June 30, 2026 2.0 billion 444.0 million
March 31, 2026 1.9 billion 424.6 million
Dec. 31, 2025 1.8 billion 398.9 million
Sept. 30, 2025 1.7 billion 385.7 million

PEN Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 32.5 million 13.7 million
March 31, 2026 73.3 million 14.6 million
Dec. 31, 2025 68.1 million 15.3 million
Sept. 30, 2025 42.0 million 15.9 million

PEN Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 34.8 million
March 31, 2026 32.6 million
Dec. 31, 2025 47.3 million
Sept. 30, 2025 45.9 million

PEN Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 658.8 million - 212.7 million
March 31, 2026 615.7 million - 216.2 million
Dec. 31, 2025 544.8 million 20.7 million 219.7 million
Sept. 30, 2025 470.3 million 21.2 million 217.0 million

PEN Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 39.6 million
March 31, 2026 39.5 million
Dec. 31, 2025 39.4 million
Sept. 30, 2025 39.3 million

PEN Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 13.5 million 25.4 million 198.5 million -
March 31, 2026 13.7 million 22.4 million 192.8 million -
Dec. 31, 2025 18.4 million 21.8 million 181.1 million -
Sept. 30, 2025 16.2 million 22.7 million 168.9 million -

PEN Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 390.0 million 125.1 million
March 31, 2026 374.8 million 121.3 million
Dec. 31, 2025 385.4 million 123.3 million
Sept. 30, 2025 354.7 million 114.3 million

PEN Revenue by Segment

Graph available only for paid members. Upgrade to see it.

PEN

Price: $327.02

52 week price:
221.26
362.41

Earnings Per Share: 4.09 USD

P/E Ratio: 79.27

Exchange: NYQ

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 268800

Ebitda: 1.8 million

Market Capitalization: 12.8 billion

Links: